secwatch.observer — SEC 8-K summary
======================================

Issuer:     Imunon, Inc. (IMNN)
CIK:        0000749647
Form:       8-K
Filed at:   2022-07-19T23:59:59+00:00
Accession:  0001493152-22-019765
Event type: leadership
Sentiment:  positive
Materiality: 0.80
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Celsion appoints Dr. Corinne Le Goff as President and CEO; Tardugno becomes Executive Chairman
--------------------------------------------------------------------------------

- Dr. Le Goff, former CCO of Moderna, named CEO effective July 18, 2022.
- New CEO base salary $624,000, signing bonus $50,000, target bonus 72% of base.
- Inducement grants: option to buy 177,000 shares at $1.95; 53,000 restricted shares.
- Michael Tardugno transitions to Executive Chairman with base salary of $500,000 (prorated to $240,000 in 2022).
- Relocation allowance up to $75,000 for two years; severance of one year's salary upon termination without cause.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/0001493152-22-019765-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/749647/000149315222019765/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-019765

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer